Piracetam

吡拉西坦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePiracetam
Drug Alias Name吡乙酰胺Piracetamum酰胺吡酮吡烷酮醋胺酰胺吡咯烷酮 +[17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsCocaine-Related DisordersMemory DisordersTardive Dyskinesia
Global Approved IndicationsMemory Disorders
Approved Indications in ChinaMemory Disorders
Original Approved Country/TerritoryN/A
Original Approved Date1971/01/01
Country/TerritoryUnited StatesIsraelMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsMemory Disorders
Inactive IndicationsCocaine-Related DisordersTardive Dyskinesia

Other Information

ATC CodeN06BX03